1268 related articles for article (PubMed ID: 12355988)
21. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer's disease: beta-Amyloid protein and tau.
Morishima-Kawashima M; Ihara Y
J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
[TBL] [Abstract][Full Text] [Related]
23. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
[TBL] [Abstract][Full Text] [Related]
24. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915
[TBL] [Abstract][Full Text] [Related]
25. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
[TBL] [Abstract][Full Text] [Related]
26. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.
Bertram L; Tanzi RE
Nat Rev Neurosci; 2008 Oct; 9(10):768-78. PubMed ID: 18802446
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
28. Genetic and environmental factors in Alzheimer's disease.
Tol J; Roks G; Slooter AJ; van Duijn CM
Rev Neurol (Paris); 1999; 155 Suppl 4():S10-6. PubMed ID: 10637933
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
[TBL] [Abstract][Full Text] [Related]
30. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
Lahiri DK; Sambamurti K; Bennett DA
Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
[TBL] [Abstract][Full Text] [Related]
32. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.
Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M
Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358
[TBL] [Abstract][Full Text] [Related]
33. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
34. Genetic study of familial cases of Alzheimer's disease.
Kowalska A; Pruchnik-Wolińska D; Florczak J; Modestowicz R; Szczech J; Kozubski W; Rossa G; Wender M
Acta Biochim Pol; 2004; 51(1):245-52. PubMed ID: 15094846
[TBL] [Abstract][Full Text] [Related]
35. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease.
Heckmann JM; Low WC; de Villiers C; Rutherfoord S; Vorster A; Rao H; Morris CM; Ramesar RS; Kalaria RN
Brain; 2004 Jan; 127(Pt 1):133-42. PubMed ID: 14570818
[TBL] [Abstract][Full Text] [Related]
36. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative.
Bennett C; Crawford F; Osborne A; Diaz P; Hoyne J; Lopez R; Roques P; Duara R; Rossor M; Mullan M
Am J Med Genet; 1995 Feb; 60(1):1-6. PubMed ID: 7485228
[TBL] [Abstract][Full Text] [Related]
37. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis.
Van Uden E; Kang DE; Koo EH; Masliah E
Microsc Res Tech; 2000 Aug; 50(4):268-72. PubMed ID: 10936878
[TBL] [Abstract][Full Text] [Related]
38. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.
Mattila KM; Forsell C; Pirttilä T; Rinne JO; Lehtimäki T; Röyttä M; Lilius L; Eerola A; St George-Hyslop PH; Frey H; Lannfelt L
Ann Neurol; 1998 Dec; 44(6):965-7. PubMed ID: 9851443
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
[TBL] [Abstract][Full Text] [Related]
40. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
